Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8.
about
Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 MutationTissue-specific expression of monocarboxylate transporters during fasting in mice.Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distributionPrenatal thyroxine treatment disparately affects peripheral and amygdala thyroid hormone levels.Congenital hypothyroidism.Increased oxidative metabolism and neurotransmitter cycling in the brain of mice lacking the thyroid hormone transporter SLC16A2 (MCT8)The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.Xenobiotic transporters: ascribing function from gene knockout and mutation studies.Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8.Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasisDifferent causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management.Thyroid hormone role on cerebellar development and maintenance: a perspective based on transgenic mouse modelsStructure and function of thyroid hormone plasma membrane transporters.The transcriptome of the Didelphis virginiana opossum kidney OK proximal tubule cell line.Evidence for a homodimeric structure of human monocarboxylate transporter 8.Expression pattern of thyroid hormone transporters in the postnatal mouse brain.Understanding the hypothalamus-pituitary-thyroid axis in mct8 deficiency.Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation.Thyroid hormones and multiple organ dysfunction syndrome
P2860
Q28118932-7A0821A2-AF51-4A75-8CB5-DA08DAA689C9Q30316982-6D6AE9C4-B630-4810-AF70-6F192CC15E2DQ33635806-79F9D585-E0ED-405F-B025-E469FC1ADA0CQ33872470-4A76C5D4-478E-4FA4-BF90-180529E58C51Q33991810-FAAC8E3A-57F3-4401-9A15-D83CC72AB66DQ35008972-E8A2BAE4-BFAE-4EA8-8184-4527D5B62BD7Q36170084-5AAC62AD-6233-4597-BDAF-103D5973F79BQ36910081-DE072390-86C1-4A27-9739-D9189D43629CQ37325277-8DA173D3-5438-493D-AEA8-0BD5C0EFC3F0Q37726622-760260A8-8D28-4077-9297-428EF94F3962Q38119993-D6D2B852-8689-49EC-8CB4-6B42682C73D9Q38218101-545FD585-FCDB-4F7A-B75E-86C188A0E56CQ38299941-92964048-EFA8-4BF7-A36C-06D065FDF3B4Q38700334-7B95585B-6B43-4624-9A7B-075DDB4FA322Q39035773-0794E0AF-1AE8-4572-91BF-BBEEEA23F240Q40825263-3E7A95B4-1A89-46FB-A042-777C617ACAEEQ41865221-ABAE2D4C-38CD-4ED2-9CE2-894BCB797541Q47219307-D8C319ED-5267-4E9F-A25C-85D470624E70Q57245280-08074281-B74F-4CA3-9750-5534511A0349
P2860
Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@ast
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@en
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@nl
type
label
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@ast
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@en
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@nl
prefLabel
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@ast
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@en
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@nl
P2093
P356
P1476
Mechanisms of disease: psychom ...... monocarboxylate transporter 8.
@en
P2093
Edith C H Friesema
Heike Heuer
Jurgen Jansen
Karl Bauer
Marija Trajkovic
Theo J Visser
P2860
P304
P356
10.1038/NCPENDMET0262
P577
2006-09-01T00:00:00Z